Re: Long-Term Disease-Specific Functioning Among Prostate Cancer Survivors and Noncancer Controls in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Editorial Comment

被引：0
|
作者：
Penson, David F.
机构：
来源：
JOURNAL OF UROLOGY | 2013年 / 189卷 / 03期
关键词：
D O I：
10.1016/j.juro.2012.11.128
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：902 / 902
页数：1
相关论文
共 50 条
  • [21] Serum Prostate-Specific Antigen Hemodilution Among Obese Men Undergoing Screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
    Grubb, Robert L., III
    Black, Amanda
    Izmirlian, Grant
    Hickey, Thomas P.
    Pinsky, Paul F.
    Mabie, Jerome E.
    Riley, Thomas L.
    Ragard, Lawrence R.
    Prorok, Philip C.
    Berg, Christine D.
    Crawford, E. David
    Church, Timothy R.
    Andriole, Gerald L., Jr.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (03) : 748 - 751
  • [22] Long-term Variation in Serum 25-Hydroxyvitamin D Concentration among Participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
    Hofmann, Jonathan N.
    Yu, Kai
    Horst, Ronald L.
    Hayes, Richard B.
    Purdue, Mark P.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (04) : 927 - 931
  • [23] LONG-TERM VARIATION IN SERUM 25-HYDROXYVITAMIN D CONCENTRATION AMONG PARTICIPANTS IN THE PROSTATE, LUNG, COLORECTAL AND OVARIAN CANCER SCREENING TRIAL
    Hofmann, J. N.
    Yu, K.
    Horst, R. L.
    Hayes, R. B.
    Purdue, M. P.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2010, 171 : S55 - S55
  • [24] Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial
    Huang, Jiaqi
    Mondul, Alison M.
    Weinstein, Stephanie J.
    Koutros, Stella
    Derkach, Andriy
    Karoly, Edward
    Sampson, Joshua N.
    Moore, Steven C.
    Berndt, Sonja I.
    Albanes, Demetrius
    BRITISH JOURNAL OF CANCER, 2016, 115 (09) : 1087 - 1095
  • [25] Metastatic prostate cancer at diagnosis and through progression in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
    Pinsk, Paul F.
    Black, Amanda
    Daugherty, Sarah E.
    Hoover, Robert
    Parnes, Howard
    Smith, Zachary L.
    Eggener, Scott
    Andriole, Gerald L.
    Berndt, Sonja, I
    CANCER, 2019, 125 (17) : 2965 - 2974
  • [26] Dietary consumption of tea and the risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial
    Thomas, Robert
    Greef, Basma
    McConnachie, Alex
    Stanley, Bethany
    Williams, Madeleine
    BRITISH JOURNAL OF NUTRITION, 2022, 128 (04) : 653 - 658
  • [27] Dietary intake of phytoestrogens and the risk of prostate cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
    Reger, Michael
    Zollinger, Terrell
    Liu, Ziyue
    Jones, Josette
    Zhang, Jianjun
    CANCER RESEARCH, 2015, 75
  • [28] Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial
    Jiaqi Huang
    Alison M Mondul
    Stephanie J Weinstein
    Stella Koutros
    Andriy Derkach
    Edward Karoly
    Joshua N Sampson
    Steven C Moore
    Sonja I Berndt
    Demetrius Albanes
    British Journal of Cancer, 2016, 115 : 1087 - 1095
  • [29] Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Prorok, PC
    Andriole, GL
    Bresalier, RS
    Buys, SS
    Chia, D
    Crawford, ED
    Fogel, R
    Gelmann, EP
    Gilbert, F
    Hasson, MA
    Hayes, RB
    Johnson, CC
    Mandel, JS
    Oberman, A
    O'Brien, B
    Oken, MM
    Rafla, S
    Reding, D
    Rutt, W
    Weissfeld, JL
    Yokochi, L
    Gohagan, JK
    CONTROLLED CLINICAL TRIALS, 2000, 21 (06): : 273S - 309S
  • [30] Prostate Cancer and PSA Among Statin Users in the Finnish Prostate Cancer Screening Trial Editorial Comment
    Walsh, Patrick C.
    JOURNAL OF UROLOGY, 2010, 184 (01): : 175 - 176
12345